Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» IPO Stock Watch: Alder Soars On Migraine Drug Results
IPO Stock Watch: Alder Soars On Migraine Drug Results
IPO Stock Watch: Alder Soars On Migraine Drug Results
Submitted by
admin
on May 16, 2015 - 2:02pm
Source:
Investors.com
News Tags:
IPOs
Alder Biopharmaceuticals
migraines
ALD403
Headline:
IPO Stock Watch: Alder Soars On Migraine Drug Results
Do Not Allow Advertisers to Use My Personal information
